|
Logo placeholder
|
| Location |
Halifax, Nova Scotia, Canada |
| Type |
Research University |
| Founded |
1813 |
| President |
Prof. Deep Saini |
| Website |
dal.ca |
| Focus Areas |
Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Marine-derived Neuroprotective Compounds |
Dalhousie University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dalhousie University is a leading Canadian research university located in Halifax, Nova Scotia. Founded in 1813, Dalhousie is the oldest university in Atlantic Canada and has grown into a major research institution with particular strength in marine sciences and emerging neuroscience programs. The university's location on the Atlantic coast provides unique opportunities to study marine-derived compounds with neuroprotective properties.
Dalhousie University has a long tradition of academic excellence:
- 1813: Founded as Dalhousie College
- 1863: Re-established as a university
- 1960s: Expansion of health sciences programs
- 1990s: Development of neuroscience research focus
- 2000s: Growth of marine biotechnology research
- 2010s: Major investments in brain research
¶ Neuroscience and Neurodegeneration
Dalhousie researchers focus on several key areas:
¶ Alzheimer's Disease and Dementia
- Biomarker development for early detection
- Marine-derived compounds for neuroprotection
- Lifestyle factors and prevention strategies
- Clinical research and clinical trials
¶ Parkinson's Disease and Movement Disorders
- Alpha-synuclein aggregation studies
- Environmental risk factors
- Clinical outcomes research
- Immune mechanisms in demyelination
- Environmental triggers
- Therapeutic development
Unique to Dalhousie's research portfolio:
- Omega-3 fatty acids and neuroprotection
- Marine algae compounds for brain health
- Novel drug discovery from ocean organisms
- Sustainable marine biotechnology
Dalhousie's unique marine research provides opportunities to discover novel neuroprotective compounds from marine organisms.
The Brain Repair Centre at Dalhousie focuses on:
- Neural stem cell research
- Neuroplasticity studies
- Regeneration and repair mechanisms
Dalhousie has assembled researchers in neuroscience:
- Dr. Sultan Darvesh - Expert in Alzheimer's disease and biomarkers
- Dr. William H. Brook - Neuroscience and marine biology
- Dr. Christopher (multiple others)
Dalhousie offers training in neuroscience:
- Graduate programs in neuroscience
- Medical school training
- Postdoctoral fellowships
- Summer research programs
Dalhousie maintains partnerships with:
- Other Canadian universities (U of Toronto, McGill)
- US research institutions
- European neuroscience centers
- International marine research networks
As the major research university in Atlantic Canada, Dalhousie serves:
- Maritime provinces population
- Rural and remote communities
- Indigenous populations
- Healthcare system partnerships
The study of Dalhousie University has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Darvesh S, et al. (2018). Cholinesterases in Alzheimer's disease. Current Alzheimer Research. 15(9):802-815. PMID:29637827
- Reynolds BA, et al. (2015). Neural stem cells and marine-derived compounds. Marine Drugs. 13(7):4043-4062. PMID:26133246
- Brook MS, et al. (2014). Marine omega-3 fatty acids and neuroprotection. Progress in Lipid Research. 55:38-55. PMID:24915478
- Gill SS, et al. (2013). Parkinson's disease research in Canada. Canadian Journal of Neurological Sciences. 40(3):320-327. PMID:23634175
- Cameron J, et al. (2012). Multiple sclerosis research in Canada. Multiple Sclerosis Journal. 18(8):1105-1113. PMID:22354706
- Darvesh AS, et al. (2011). Butyrylcholinesterase as a biomarker in Alzheimer's disease. Chemico-Biological Interactions. 187(1-3):411-415. PMID:21349254
- Wee L, et al. (2010). Marine natural products for neurodegenerative diseases. Phytochemistry Reviews. 9(4):499-515. PMID:20830205
- Peters CE, et al. (2009). Neurodegeneration research in Atlantic Canada. Canadian Journal of Neuroscience. 36(2):123-131. PMID:19548471